Pimozide, an inhibitor of USP1, results in the arrest of adult T-cell leukemia cells in the G1 phase, leading to the accumulation of p21 and p27 and reduction in the protein levels of cyclin D2, cyclin E, CDK2, CDK4, and CDK6 [36]. The gene discussed is CDK2; the disease is T-cell leukemia.